Questions discussed in this category
4 months of Neoadjuvant GAP resulted in conversion from unresectable to resectable.
In light of CheckMate 816 and IMpower010 and FDA approval for neoadjuvant chemo-nivolumab and adjuvant chemo-atezolizumab, how do you decide which sys...
How much weight do you give to a hgb/hct threshold versus symptoms?
Venetoclax has demonstrated efficacy in patients harboring t(11;14) mutations but is not FDA approved for MM. Can you expand on what situations you ma...
Does the 2020 approval of Nivolumab and Ipilimumab for mNSCLC with PDL1 >1% impact your decision?
How do you decide how long to continue?
Pathology is not carcinoid or small cell.
The patient remains without evidence of systemic disease outside of the CNS on serial imaging. Would you continue treating with SRS as lesions appear,...
Would you continue to trend ctDNA to detect early recurrence?
What are the risks of infection with COVID-19 if using immunotherapy?
Do you ever consider stopping if stable disease and good tolerance?
PET-CT and Brain MRI are negative for other evidence of disease.
What would be the next line of treatment, PRRT, capecitabine and temozolomide or other?
In a patient with lung cancer with both NSCLC and SCLC components, would you offer carbo/pem/pembro or carbo/etoposide/atezolizumab? Or any other alte...
Does your approach differ by EBV status?
Would you give adjuvant chemotherapy or start osimertinib?
Would you offer chemotherapy alone per data from BILCAP or is there any role of radiation?
There is no evidence of disease outside the lung on PET, and the patient is completely asymptomatic with negative EGFR, ALK, ROS1, and BRAF and a PD-L...
How would the new data presented at ASCO GI 2021 from from Alliance A021501 influence your answer?
16037151311279510796120917175117991137787247650754366916884451664383715609044295283528750754105430742863862714
Papers discussed in this category
International journal of radiation oncology, biology, physics, 2009-01-01
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2011-12-10
BMC Cancer, 2018 Jan 11
J. Clin. Oncol., 2020 Feb 20
J Clin Oncol, 2019 Jun 02
N. Engl. J. Med., 2019 May 31
The New England journal of medicine, 2018-12-06
J Thorac Oncol, 2019 Jan 18
Int J Cancer, 2018 Apr 15
JAMA Oncol, 2019 Oct 31
Eur J Surg Oncol, 2014 Oct 07
Annals of surgical oncology, 2018-08
Lancet, 2019 Oct 04
The New England journal of medicine, 2018-05-31
Lancet (London, England), 2019-05-04
J Clin Oncol, 2020 May 10
J Thorac Oncol, 2021 Oct 12
British journal of cancer, 2005-03-14
Case Rep Oncol, 2020 Jan 21
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2013-11-01
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2009-11-01
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2015-09
J Thorac Dis,
JAMA, 2016-11-15
N Engl J Med,
J Clin Oncol, 2019 Apr 10
J Clin Oncol, 2020 Feb 21
Blood cancer journal, 2018-06-12
J. Clin. Oncol., 2019 Oct 25
JAMA Oncol,
Lancet Oncol, 2019 Oct 23
Lancet Oncol, 2020 Oct 29
J Clin Oncol, 2021 Aug 13
Blood Adv, 2021 Sep 01
N Engl J Med, 2017 Nov 16
N Engl J Med, 2020 Sep 19
Lancet, 2021 Sep 20
N Engl J Med, 2022 Apr 11
Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract, 2007-11
Annals of surgery, 2010-03
Cancer, 2016-02-15
Cancer, 2019-01-01
HPB : the official journal of the International Hepato Pancreato Biliary Association, 2017-07
N. Engl. J. Med.,
Lancet Oncol., 2019 Mar 25